Pointing Fingers: Accusations fly as Roche-Cipla continue to lockhorns.
The latest in the Roche- Cipla patent war are allegations of wrongful promotion of Erlocip. This is the same drug that Roche held a patent for, but Cipla continued to manufacture in India. Readers will remember Shamnad’s extensive post on the Roche-Cipla judgment that revolved around this very drug. As per the letter dated 27 March, 2008, Cipla allegedly distributed promotional literature on Erlocip for the treatment of four kinds of cancer (non-small lung cell, pancreatic, neck & head cancer…
Read More